Journal
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
Volume 14, Issue 3, Pages 221-227Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/S0928-0987(01)00183-X
Keywords
prodrug; aspirin; ISMN; nitric oxide; platelet inhibition
Categories
Ask authors/readers for more resources
Two isomeric aspirin derivatives of isosorbide-5-mononitrate (ISMN) were prepared and evaluated as potential mutual prodrugs of aspirin and nitric oxide. The hydrolysis of both compounds was studied in pH 7.4 phosphate buffer solution, buffered alpha -chymotrypsin solution and 10% buffered rabbit plasma. The benzodioxin-4-one derivative was hydrolysed to salicylic acid and ISMN acetate in buffer solution (t(1/2) 32. t h), 10% buffered rabbit plasma (t(1/2) 25.7 min) and alpha -chymotrypsin (t(1/2) 86.6 min). The carboxylic acid ester derivative ISMNA was hydrolysed via the salicylate ester in buffer solution (t(1/2) 48.5 h) but was rapidly and almost exclusively hydrolysed to aspirin and ISMN in plasma solution (t(1/2) 2.8 min). The hydrolysis appeared to be enzyme mediated as it was suppressed by co-incubation with eserine. ISMNA was evaluated for its ability to inhibit platelet aggregation in rabbit PRP in response to the following agonists: arachidonic acid (AA) (100 muM), ADP (1.2 muM) phorbol ester (0.5 muM). platelet activating factor (PAF) (5 nM) and the thromboxane mimic U46619 (1.5 muM). ISMNA suppressed platelet response to AA at 1 muM whereas 10 muM aspirin showed no inhibitory effects. (C) 2001 Published by Elsevier Science B.V.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available